The US-China trade war began with disputes over the transfer of technology to China, including forced technology transfer. How much has the licensing environment improved for the foreign business community? How will China’s developing antitrust regime affect foreign businesses seeking to monetize their IP in China? Considering joining us at next week’s webinar (June 03, 2020, 4:30 – 5:45 PM PST) (previous posting had a typo!). The speakers are Hao Yuan (Tsinghua Law School/Berkeley Law); Stuart Chemtob (Wilson Sonsini); Deng Fei (Charles River Associates); David Dutcher (Western Digital) and Robert Merges (Berkeley Law). Here is the link to the series description, and to the registration. This series/program incurs a charge, except for students/media/BCLT and other benefactors.
In another licensing-related development, on June 16, 2020, from 12-1pm EDT, I will be speaking along with Jim Harlan, Senior Director, Standards & Competition Policy, InterDigital, Inc on the US Department of Commerce’s Bureau of Industry and Security’s (BIS) ban of Huawei and its effect on global Standards Developing Organizations (SDOs). This program is sponsored by the American Intellectual Property Law Association’s Standards and Open Source Committee. Non-AIPLA members may join this open event. Call: +1 (347) 991-7204, passcode 251151532.
A video of the recent webinar we hosted at Berkeley on “Following the Data: What the Latest Research Says About China’s Legal and IP Environment” with Ben Liebman, Tobias Smith, Fei Deng, Melissa Schneider and Robert Merges is found here. China Daily’s reporting on the IP Aspects of that program is found here.
Finally, I recently was interviewed by Pinduoduo on e-commerce regulation in China and IP. Here is a link to the podcast on Spotify.
On May 27, 2020, Berkeley Law will be hosting the first in a seven-part series on Chinese IP. The series will provide CLE credit. Attendees are also eligible for a certificate upon completion of the series. You can choose to attend individual classes without the certificate, or the series ($50.00/$299.00). Here is the information on the pharma program:
Session 1: May 27, 2020 – Pharmaceutical IP Issues / 4:30 P.M. (PT) – 90 min.
Pharmaceutical IP protection was a big “winner” in the Phase 1 Trade Agreement. How is China planning on implementing its commitments to improve protection for innovative chemical compounds and biologics?
- Chief Judge Randall Rader (ret.)
- He Jing, Anjie Law Firm
- Zhao Xu, East China University of Politics and Law
- Tony Chen, Jones Day
- Karen Guo, Novo Nordisk
- Moderator: Mark Cohen, Berkeley Law
$50 single session registration fee
There will also be a separate round-table scheduled for June 8 on patent linkage in conjunction with this event (no additional fee). Details to be announced on Wednesday.
The Webinar series will cover some of the “hottest” topics in China IP issues including trade secret protection, abusive trademark registrations, developments in copyright law, pharmaceutical IP developments, enforcement issues, licensing and antitrust, trade secrets, and the emerging different in patent prosecution practices in AI, software-enabled inventions and diagnostics. Speakers include faculty from Berkeley Law and other institutions, former Chief Judges Rader and Michel, former USPTO Director Kappos, along with many other experts.
The seminar US and China Intellectual Property Dialogue – Latest Developments of Intellectual Property Law and Enforcement will be held this Thursday, October 2, 2014 at the Hyatt Regency, Santa Clara. Additional information is also at http://svipla.org/event-1712495 or via email from info@chinaIPfund.org. The program will include such notables as former PTO Director Bruce Lehman, former SIPO Commissioner Gao Lulin, Former SIPO DG of Law and Treaties, Yin Xintian, and John Cabeca and Elaine Wu from USPTO. It is free of charge, including breakfast, lunch, and coffee breaks with cocktail reception to follow.
The next day, on October 3, the University of Toledo Law School will be sponsoring another all day program “Doing Business in China: A Legal and Commercial Review”. The fee is only $35.00 and also includes a solid bench, including Tom Moga, Peter Yu, Elizabeth Lai Featherman and me talking about IP issues. CLE credit is available.